Cat: IPD-X12334

Recombinant Mouse IFN-alpha B/IFNA8 Protein(HEK293), N-His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

Quality inspection process

Protein Description

Interferon-alpha B (IFN-alpha B or IFNA8) is a member of the type I interferon family, which plays a crucial role in the innate immune response against viral infections and other pathogens. IFNA8 is primarily produced by plasmacytoid dendritic cells (pDCs) and is known for its antiviral, antiproliferative, and immunomodulatory effects. Research into IFNA8 has gained momentum due to its potential therapeutic applications in treating viral infections, autoimmune diseases, and certain types of cancers. The reconstitution and study of recombinant IFN-alpha B proteins have become pivotal in understanding their biological mechanisms, receptor interactions, and signaling pathways. Moreover, the ability to produce these proteins in sufficient quantities allows for in-depth functional assays and the exploration of their clinical utility in enhancing immune responses. Investigations into the structure-function relationship of IFNA8 are also essential for optimizing its efficacy and decreasing potential side effects in therapeutic applications. Overall, continued research on IFN-alpha B is vital for unveiling new insights into immune modulation and developing innovative strategies for disease intervention.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US